ABCMdb

PMID: 11589832

Aitken ML, Moss RB, Waltz DA, Dovey ME, Tonelli MR, McNamara SC, Gibson RL, Ramsey BW, Carter BJ, Reynolds TC
A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease.
Hum Gene Ther. 2001 Oct 10;12(15):1907-16., 2001-10-10 [PubMed]

Sentences

No. Mutations Sentence Comment

156 ABCC7 p.Gly551Asp ABCC7 p.Gly551Asp ABCC7 p.Arg334Trp ABCC7 p.Arg347Pro SUBJECT DEMOGRAPHICS Age Day (214) tgAAVCF Subject Gender (years) CF mutation FEV1% dose 101 M 29 F508/F508 71 1010 102 F 40 F508/unknown 90 1010 103 F 34 F508/unknown 79 1010 301 M 37 F508/F508 63 1011 104 F 28 F508/unknown 104 1011 105 F 38 F508/F508 79 1011 201 F 29 F508/unknown 99 1012 302 M 24 F508/R347P 65 1012 106 F 28 F508/R334W 69 1012 203 M 41 G551D/G551D 64 1013 303 M 19 F508/F508 82 1013 107 F 26 F508/unknown 75 1013 TABLE 2. Login to comment